Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.
- DOI
- 10.1016/j.eclinm.2026.104164
- Published
- 2026 Sep
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.104164,
title = {Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.},
author = {Pike JR and Huang AR and Reed N and Arnold ML and Chisolm TH and Couper D and Deal JA and Faucette S and Goman AM and Gottesman RF and Hughes TM and Knopman D and Mitchell C and Mosley TH and Palta P and Pankow JS and Sanchez VA and Selvin E and Sullivan KJ and Thyagarajan B and Wagenknecht LE and Lin FR and Coresh J and ACHIEVE Collaborative Research Groups and ACHIEVE Collaborative Research Group},
year = {2026},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2026.104164},
url = {https://doi.org/10.1016/j.eclinm.2026.104164}
}RIS
TY - JOUR TI - Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial. AU - Pike JR AU - Huang AR AU - Reed N AU - Arnold ML AU - Chisolm TH AU - Couper D AU - Deal JA AU - Faucette S AU - Goman AM AU - Gottesman RF AU - Hughes TM AU - Knopman D AU - Mitchell C AU - Mosley TH AU - Palta P AU - Pankow JS AU - Sanchez VA AU - Selvin E AU - Sullivan KJ AU - Thyagarajan B AU - Wagenknecht LE AU - Lin FR AU - Coresh J AU - ACHIEVE Collaborative Research Groups AU - ACHIEVE Collaborative Research Group PY - 2026 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2026.104164 UR - https://doi.org/10.1016/j.eclinm.2026.104164 ER -
APA
JR, P., AR, H., N, R., ML, A., TH, C., D, C., JA, D., S, F., AM, G., RF, G., TM, H., D, K., C, M., TH, M., P, P., JS, P., VA, S., E, S., KJ, S., B, T., LE, W., FR, L., J, C., Groups, A. C. R., & Group, A. C. R. (2026). Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104164
Source records
- pubmed · retrieved 2026-09-25T20:25:24.052Z